EEG activation with Dimefline hydrochloride.
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D006259:Craniocerebral Trauma / Q000150:complications; D004569:Electroencephalography; D004827:Epilepsy / Q000175:diagnosis / Q000503:physiopathology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008607:Intellectual Disability / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000503:physiopathology; D009290:Narcolepsy / Q000503:physiopathology; D009497:Neurotic Disorders / Q000503:physiopathology; D010433:Pentylenetetrazole / Q000494:pharmacology; D012559:Schizophrenia / Q000503:physiopathology; D013268:Stimulation, Chemical
D000697:Central Nervous System Stimulants; D005419:Flavonoids; D010433:Pentylenetetrazole